Senior Medical Advisor, William Reisacher, interviewed on the Price of Business with Kevin Price In the News / By Intrommune
Proactive Interview: Intrommune Therapeutics moving its peanut allergy treatment through the FDA approval process In the News / By Intrommune
Providing Innovative Treatments for Peanut Allergies Intrommune CEO, Michael Nelson, interview on the Price of Business with Kevin Price In the News / By Intrommune
Science News: Liquid mouth drops could one day protect people from peanut allergies In the News / By Intrommune
Intrommune Therapeutics selected as one of the RESI NYC Innovation Challenge Finalists In the News / By Intrommune
